Burning Rock Biotech Limited - stock earnings
BNR Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| June 4, 2024 BeforeMarket | - / - | - | - / 109.3 million | - |
BNR Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -24.0 million USD | 17.5 million USD |
| 2023Q2 | -18.1 million USD | 20.2 million USD |
| 2023Q1 | -31.5 million USD | 20.7 million USD |
| 2022Q4 | -26.9 million USD | 20.7 million USD |
| 2022Q3 | -31.8 million USD | 21.8 million USD |
| 2022Q2 | -33.8 million USD | 23.1 million USD |
| 2022Q1 | -39.6 million USD | 23.2 million USD |
| 2021Q4 | -40.6 million USD | 21.3 million USD |
| 2021Q3 | -26.4 million USD | 19.6 million USD |
| 2021Q2 | -31.5 million USD | 19.7 million USD |
| 2021Q1 | -26.2 million USD | 16.3 million USD |
| 2020Q4 | -24.0 million USD | 20.2 million USD |
| 2020Q3 | -18.7 million USD | 18.2 million USD |
| 2020Q2 | -10.1 million USD | 15.1 million USD |
| 2020Q1 | -7.4 million USD | 9.5 million USD |
| 2019Q4 | -13.6 million USD | 12.7 million USD |
| 2019Q3 | -4.5 million USD | 14.6 million USD |
| 2019Q2 | -3.8 million USD | 12.3 million USD |
| 2019Q1 | -2.4 million USD | 15.5 million USD |
BNR Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -100.0 million USD | 78.9 million USD |
| 2022 | -141.0 million USD | 81.7 million USD |
| 2021 | -125.4 million USD | 79.9 million USD |
| 2020 | -57.2 million USD | 65.8 million USD |
| 2019 | -24.1 million USD | 54.7 million USD |
| 2018 | -25.8 million USD | 30.4 million USD |
| 2017 | -20.1 million USD | 17.0 million USD |
BNR
Price: $0.81
52 week price:
Earnings Per Share: -0.96 USD
P/E Ratio: -0.88
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 139800
Market Capitalization: 73.4 million